Home > > > Report Detail

Global Artemisinin Combination Therapy Market Growth (Status and Outlook) 2019-2024

Publisher Name :
Date: 09-Jan-2020
No. of pages: 132

According to this study, over the next five years the Artemisinin Combination Therapy market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global revenue market share of key companies in Artemisinin Combination Therapy business, shared in Chapter 3.

This report presents a comprehensive overview, market shares and growth opportunities of Artemisinin Combination Therapy market by product type, application, key companies and key regions.

This study considers the Artemisinin Combination Therapy value generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019 in Section 2.3; and forecast to 2024 in section 10.7.

- Artemether+Lumefantrine

- Artesunate+Amodiaquine

- Dihydroartemisinin+Piperaquine

- Artesunate+Mefloquine

- Artesunate+Sulfadoxine-Pyrimethamine

- Pyronaridine-Artesunate

- Other

Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 10.8.

- Hospital

- Clinic

- Other

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- United States

- Canada

- Mexico

- Brazil

- APAC

- China

- Japan

- Korea

- Southeast Asia

- India

- Australia

- Europe

- Germany

- France

- UK

- Italy

- Russia

- Spain

- Middle East & Africa

- Egypt

- South Africa

- Israel

- Turkey

- GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- KPC Pharmaceuticals

- Ipca Laboratories

- Shanghai Fosun Pharmaceutical Industrial Development

- Desano Holdings

- Calyx Chemicals and Pharmaceuticals

- Sanofi

- Denk Pharma

- Mylan

- Hovid Berhad

- Novartis

- Cipla

- Guilin Pharmaceuticals

- Ajanta Pharma

- Aspen Pharmacare Holdings

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key players and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Artemisinin Combination Therapy market size by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.

- To understand the structure of Artemisinin Combination Therapy market by identifying its various subsegments.

- Focuses on the key global Artemisinin Combination Therapy players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Artemisinin Combination Therapy with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the size of Artemisinin Combination Therapy submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Artemisinin Combination Therapy Market Growth (Status and Outlook) 2019-2024

Table of Contents

Global Artemisinin Combination Therapy Market Growth (Status and Outlook) 2019-2024

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Artemisinin Combination Therapy Market Size 2014-2024
2.1.2 Artemisinin Combination Therapy Market Size CAGR by Region
2.2 Artemisinin Combination Therapy Segment by Type
2.2.1 Artemether+Lumefantrine
2.2.2 Artemether+Lumefantrine
2.2.3 Dihydroartemisinin+Piperaquine
2.2.4 Artesunate+Mefloquine
2.2.5 Artesunate+Sulfadoxine-Pyrimethamine
2.2.6 Pyronaridine-Artesunate
2.2.7 Other
2.3 Artemisinin Combination Therapy Market Size by Type
2.3.1 Global Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
2.3.2 Global Artemisinin Combination Therapy Market Size Growth Rate by Type (2014-2019)
2.4 Artemisinin Combination Therapy Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Other
2.5 Artemisinin Combination Therapy Market Size by Application
2.5.1 Global Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
2.5.2 Global Artemisinin Combination Therapy Market Size Growth Rate by Application (2014-2019)

3 Global Artemisinin Combination Therapy by Players
3.1 Global Artemisinin Combination Therapy Market Size Market Share by Players
3.1.1 Global Artemisinin Combination Therapy Market Size by Players (2017-2019)
3.1.2 Global Artemisinin Combination Therapy Market Size Market Share by Players (2017-2019)
3.2 Global Artemisinin Combination Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Artemisinin Combination Therapy by Regions
4.1 Artemisinin Combination Therapy Market Size by Regions
4.2 Americas Artemisinin Combination Therapy Market Size Growth
4.3 APAC Artemisinin Combination Therapy Market Size Growth
4.4 Europe Artemisinin Combination Therapy Market Size Growth
4.5 Middle East & Africa Artemisinin Combination Therapy Market Size Growth

5 Americas
5.1 Americas Artemisinin Combination Therapy Market Size by Countries
5.2 Americas Artemisinin Combination Therapy Market Size by Type
5.3 Americas Artemisinin Combination Therapy Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Artemisinin Combination Therapy Market Size by Countries
6.2 APAC Artemisinin Combination Therapy Market Size by Type
6.3 APAC Artemisinin Combination Therapy Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Artemisinin Combination Therapy by Countries
7.2 Europe Artemisinin Combination Therapy Market Size by Type
7.3 Europe Artemisinin Combination Therapy Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Artemisinin Combination Therapy by Countries
8.2 Middle East & Africa Artemisinin Combination Therapy Market Size by Type
8.3 Middle East & Africa Artemisinin Combination Therapy Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Artemisinin Combination Therapy Market Forecast
10.1 Global Artemisinin Combination Therapy Market Size Forecast (2019-2024)
10.2 Global Artemisinin Combination Therapy Forecast by Regions
10.2.1 Global Artemisinin Combination Therapy Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Artemisinin Combination Therapy Forecast by Type
10.8 Global Artemisinin Combination Therapy Forecast by Application

11 Key Players Analysis
11.1 KPC Pharmaceuticals
11.1.1 Company Details
11.1.2 Artemisinin Combination Therapy Product Offered
11.1.3 KPC Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 KPC Pharmaceuticals News
11.2 Ipca Laboratories
11.2.1 Company Details
11.2.2 Artemisinin Combination Therapy Product Offered
11.2.3 Ipca Laboratories Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 Ipca Laboratories News
11.3 Shanghai Fosun Pharmaceutical Industrial Development
11.3.1 Company Details
11.3.2 Artemisinin Combination Therapy Product Offered
11.3.3 Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Shanghai Fosun Pharmaceutical Industrial Development News
11.4 Desano Holdings
11.4.1 Company Details
11.4.2 Artemisinin Combination Therapy Product Offered
11.4.3 Desano Holdings Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 Desano Holdings News
11.5 Calyx Chemicals and Pharmaceuticals
11.5.1 Company Details
11.5.2 Artemisinin Combination Therapy Product Offered
11.5.3 Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Calyx Chemicals and Pharmaceuticals News
11.6 Sanofi
11.6.1 Company Details
11.6.2 Artemisinin Combination Therapy Product Offered
11.6.3 Sanofi Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Sanofi News
11.7 Denk Pharma
11.7.1 Company Details
11.7.2 Artemisinin Combination Therapy Product Offered
11.7.3 Denk Pharma Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.7.4 Main Business Overview
11.7.5 Denk Pharma News
11.8 Mylan
11.8.1 Company Details
11.8.2 Artemisinin Combination Therapy Product Offered
11.8.3 Mylan Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.8.4 Main Business Overview
11.8.5 Mylan News
11.9 Hovid Berhad
11.9.1 Company Details
11.9.2 Artemisinin Combination Therapy Product Offered
11.9.3 Hovid Berhad Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.9.4 Main Business Overview
11.9.5 Hovid Berhad News
11.10 Novartis
11.10.1 Company Details
11.10.2 Artemisinin Combination Therapy Product Offered
11.10.3 Novartis Artemisinin Combination Therapy Revenue, Gross Margin and Market Share (2017-2019)
11.10.4 Main Business Overview
11.10.5 Novartis News
11.11 Cipla
11.12 Guilin Pharmaceuticals
11.13 Ajanta Pharma
11.14 Aspen Pharmacare Holdings

12 Research Findings and Conclusion

List of Tables and Figures

Table Product Specifications of Artemisinin Combination Therapy
Figure Artemisinin Combination Therapy Report Years Considered
Figure Market Research Methodology
Figure Global Artemisinin Combination Therapy Market Size Growth Rate 2014-2024 ($ Millions)
Table Artemisinin Combination Therapy Market Size CAGR by Region 2014-2024 ($ Millions)
Table Major Players of Artemether+Lumefantrine
Table Major Players of Artesunate+Amodiaquine
Table Major Players of Dihydroartemisinin+Piperaquine
Table Major Players of Artesunate+Mefloquine
Table Major Players of Artesunate+Sulfadoxine-Pyrimethamine
Table Major Players of Pyronaridine-Artesunate
Table Major Players of Other
Table Market Size by Type (2014-2019) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure Global Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure Global Artemether+Lumefantrine Market Size Growth Rate
Figure Global Artesunate+Amodiaquine Market Size Growth Rate
Figure Global Dihydroartemisinin+Piperaquine Market Size Growth Rate
Figure Global Artesunate+Mefloquine Market Size Growth Rate
Figure Global Artesunate+Sulfadoxine-Pyrimethamine Market Size Growth Rate
Figure Global Pyronaridine-Artesunate Market Size Growth Rate
Figure Global Other Market Size Growth Rate
Figure Artemisinin Combination Therapy Consume????!D in Hospital
Figure Global Artemisinin Combination Therapy Market: Hospital (2014-2019) ($ Millions)
Figure Global Hospital YoY Growth ($ Millions)
Figure Artemisinin Combination Therapy Consume????!D in Clinic
Figure Global Artemisinin Combination Therapy Market: Clinic (2014-2019) ($ Millions)
Figure Global Clinic YoY Growth ($ Millions)
Figure Artemisinin Combination Therapy Consume????!D in Other
Figure Global Artemisinin Combination Therapy Market: Other (2014-2019) ($ Millions)
Figure Global Other YoY Growth ($ Millions)
Table Global Artemisinin Combination Therapy Market Size by Application (2014-2019) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure Global Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure Global Artemisinin Combination Therapy Market Size in Hospital Growth Rate
Figure Global Artemisinin Combination Therapy Market Size in Clinic Growth Rate
Figure Global Artemisinin Combination Therapy Market Size in Other Growth Rate
Table Global Artemisinin Combination Therapy Revenue by Players (2017-2019) ($ Millions)
Table Global Artemisinin Combination Therapy Revenue Market Share by Players (2017-2019)
Figure Global Artemisinin Combination Therapy Revenue Market Share by Players in 2018
Table Global Artemisinin Combination Therapy Key Players Head office and Products Offered
Table Artemisinin Combination Therapy Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table Global Artemisinin Combination Therapy Market Size by Regions 2014-2019 ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share by Regions 2014-2019
Figure Global Artemisinin Combination Therapy Market Size Market Share by Regions 2014-2019
Figure Americas Artemisinin Combination Therapy Market Size 2014-2019 ($ Millions)
Figure APAC Artemisinin Combination Therapy Market Size 2014-2019 ($ Millions)
Figure Europe Artemisinin Combination Therapy Market Size 2014-2019 ($ Millions)
Figure Middle East & Africa Artemisinin Combination Therapy Market Size 2014-2019 ($ Millions)
Table Americas Artemisinin Combination Therapy Market Size by Countries (2014-2019) ($ Millions)
Table Americas Artemisinin Combination Therapy Market Size Market Share by Countries (2014-2019)
Figure Americas Artemisinin Combination Therapy Market Size Market Share by Countries in 2018
Table Americas Artemisinin Combination Therapy Market Size by Type (2014-2019) ($ Millions)
Table Americas Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure Americas Artemisinin Combination Therapy Market Size Market Share by Type in 2018
Table Americas Artemisinin Combination Therapy Market Size by Application (2014-2019) ($ Millions)
Table Americas Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure Americas Artemisinin Combination Therapy Market Size Market Share by Application in 2018
Figure United States Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Canada Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Mexico Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Table APAC Artemisinin Combination Therapy Market Size by Countries (2014-2019) ($ Millions)
Table APAC Artemisinin Combination Therapy Market Size Market Share by Countries (2014-2019)
Figure APAC Artemisinin Combination Therapy Market Size Market Share by Countries in 2018
Table APAC Artemisinin Combination Therapy Market Size by Type (2014-2019) ($ Millions)
Table APAC Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure APAC Artemisinin Combination Therapy Market Size Market Share by Type in 2018
Table APAC Artemisinin Combination Therapy Market Size by Application (2014-2019) ($ Millions)
Table APAC Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure APAC Artemisinin Combination Therapy Market Size Market Share by Application in 2018
Figure China Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Japan Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Korea Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Southeast Asia Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure India Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Australia Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Table Europe Artemisinin Combination Therapy Market Size by Countries (2014-2019) ($ Millions)
Table Europe Artemisinin Combination Therapy Market Size Market Share by Countries (2014-2019)
Figure Europe Artemisinin Combination Therapy Market Size Market Share by Countries in 2018
Table Europe Artemisinin Combination Therapy Market Size by Type (2014-2019) ($ Millions)
Table Europe Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure Europe Artemisinin Combination Therapy Market Size Market Share by Type in 2018
Table Europe Artemisinin Combination Therapy Market Size by Application (2014-2019) ($ Millions)
Table Europe Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure Europe Artemisinin Combination Therapy Market Size Market Share by Application in 2018
Figure Germany Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure France Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure UK Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Italy Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Russia Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Spain Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Table Middle East & Africa Artemisinin Combination Therapy Market Size by Countries (2014-2019) ($ Millions)
Table Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Countries (2014-2019)
Figure Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Countries in 2018
Table Middle East & Africa Artemisinin Combination Therapy Market Size by Type (2014-2019) ($ Millions)
Table Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type (2014-2019)
Figure Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Type in 2018
Table Middle East & Africa Artemisinin Combination Therapy Market Size by Application (2014-2019) ($ Millions)
Table Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application (2014-2019)
Figure Middle East & Africa Artemisinin Combination Therapy Market Size Market Share by Application in 2018
Figure Egypt Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure South Africa Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Israel Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Turkey Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure GCC Countries Artemisinin Combination Therapy Market Size Growth 2014-2019 ($ Millions)
Figure Global Artemisinin Combination Therapy arket Size Forecast (2019-2024) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Forecast by Regions (2019-2024) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share Forecast by Regions
Figure Americas Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure APAC Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Europe Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Middle East & Africa Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure United States Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Canada Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Mexico Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Brazil Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure China Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Japan Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Korea Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Southeast Asia Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure India Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Australia Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Germany Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure France Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure UK Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Italy Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Russia Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Spain Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Egypt Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure South Africa Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Israel Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure Turkey Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Figure GCC Countries Artemisinin Combination Therapy Market Size 2019-2024 ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Forecast by Type (2019-2024) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share Forecast by Type (2019-2024)
Table Global Artemisinin Combination Therapy Market Size Forecast by Application (2019-2024) ($ Millions)
Table Global Artemisinin Combination Therapy Market Size Market Share Forecast by Application (2019-2024)
Table KPC Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table KPC Pharmaceuticals Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure KPC Pharmaceuticals Artemisinin Combination Therapy Market Share (2017-2019)
Table Ipca Laboratories Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ipca Laboratories Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Ipca Laboratories Artemisinin Combination Therapy Market Share (2017-2019)
Table Shanghai Fosun Pharmaceutical Industrial Development Basic Information, Head Office, Major Market Areas and Its Competitors
Table Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Shanghai Fosun Pharmaceutical Industrial Development Artemisinin Combination Therapy Market Share (2017-2019)
Table Desano Holdings Basic Information, Head Office, Major Market Areas and Its Competitors
Table Desano Holdings Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Desano Holdings Artemisinin Combination Therapy Market Share (2017-2019)
Table Calyx Chemicals and Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Calyx Chemicals and Pharmaceuticals Artemisinin Combination Therapy Market Share (2017-2019)
Table Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table Sanofi Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Sanofi Artemisinin Combination Therapy Market Share (2017-2019)
Table Denk Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Denk Pharma Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Denk Pharma Artemisinin Combination Therapy Market Share (2017-2019)
Table Mylan Basic Information, Head Office, Major Market Areas and Its Competitors
Table Mylan Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Mylan Artemisinin Combination Therapy Market Share (2017-2019)
Table Hovid Berhad Basic Information, Head Office, Major Market Areas and Its Competitors
Table Hovid Berhad Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Hovid Berhad Artemisinin Combination Therapy Market Share (2017-2019)
Table Novartis Basic Information, Head Office, Major Market Areas and Its Competitors
Table Novartis Artemisinin Combination Therapy Revenue and Gross Margin (2017-2019)
Figure Novartis Artemisinin Combination Therapy Market Share (2017-2019)
Table Cipla Basic Information, Head Office, Major Market Areas and Its Competitors
Table Guilin Pharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table Ajanta Pharma Basic Information, Head Office, Major Market Areas and Its Competitors
Table Aspen Pharmacare Holdings Basic Information, Head Office, Major Market Areas and Its Competitors
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs